Hepatitis

The Pharmacy Times® Hepatitis Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of a group of distinct diseases that cause inflammation of the liver, including hepatitis A, B, C, and D.

Latest News

Image Credit: © Yura Yarema - stock.adobe.com
FDA Grants Survodutide Breakthrough Therapy Designation for Treatment of Adults With MASH

October 8th 2024

Survodutide is a glucagon/glucagon-like peptide-1 (GLP-1) receptor dual agonist that activates the glucagon and GLP-1 receptors to better control metabolic function.

Photomicrograph of liver biopsy in a patient with cirrhosis, showing bridging septal fibrosis and regenerative nodules.
FDA Grants Denifanstat Breakthrough Therapy Designation for Treatment of MASH

October 2nd 2024

Human liver anatomy with hepatitis B virus.
Minority of Hematology Patients Receive Hepatitis B Screening Prior to Intravenous Immunoglobulin Exposure

July 29th 2024

Image Credit: © eddows - stock.adobe.com
Persistent Epigenetic Changes in Immune Cells Following Hepatitis C Recovery

July 26th 2024

Pharmacist telling a female patient about her treatment
Pharmacists Boost Hepatitis D Treatment Success with Hands-On Education

July 9th 2024

Video Interviews

More News